DexCom Inc (DXCM)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $31.08B
Last updated: Nov 17, 2026 at 11:05 AM ET
DexCom Inc (DXCM) P/E Ratio & Valuation History
DexCom (DXCM) trades at 30.6x trailing earnings and 6.0x sales. Its P/E of 30.6x is below its 5-year median of 67.5x. Its forward P/E is 26.9x. The median P/E across 8 similar companies is 19.4x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 13.8% higher over the next year. Its free cash flow yield is 3.6%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 30.6x |
| Forward P/E | 26.9x |
| Price to sales | 6.0x |
| Price to book | 12.1x |
| EV/EBITDA | 20.1x |
| Price to FCF | 27.8x |
| EV/FCF | 28.1x |
| PEG | 1.3 |
| FCF yield | 3.6% |
Historical Medians
Against its 10-year medians, its P/S is 47.4% below 11.4x and its P/B is 37.9% below 19.5x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 30.6x | 67.5x | N/A |
| P/S | 6.0x | 8.4x | 11.4x |
| P/B | 12.1x | 15.7x | 19.5x |
Valuation History
Over the 8 of the 10 year ends shown that have a P/E, its P/E ranged from 31.8x in 2025 to 374.4x in 2018. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $66.37 | 31.8x | 5.6x | 9.6x |
| 2024 | $77.77 | 47.1x | 7.7x | 15.0x |
| 2023 | $124.09 | 82.2x | 13.5x | 24.9x |
| 2022 | $113.24 | 130.2x | 18.7x | 22.6x |
| 2021 | $134.24 | 203.4x | 27.4x | 24.3x |
| 2020 | $92.43 | 118.5x | 23.2x | 78.9x |
| 2019 | $54.69 | 118.9x | N/A | 23.0x |
| 2018 | $29.95 | 374.4x | 12.6x | 21.9x |
| 2017 | $14.35 | N/A | 6.9x | 11.9x |
| 2016 | $14.93 | N/A | 8.7x | 17.8x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About DXCM
What is DXCM's forward P/E ratio?
DexCom has a forward P/E ratio of 26.9x.
Is DXCM stock overvalued?
GNG's valuation label for DXCM is Undervalued. Its P/E of 30.6x compares with a median of 19.4x across 8 similar companies.
What is DXCM's price to sales ratio?
DexCom has a price to sales ratio of 6.0x.
What is DexCom's average P/E ratio over 5 years?
DexCom's median P/E over the last 5 years is 67.5x, from 60 month-end values through Oct 2026.
What is DXCM's PEG ratio?
DexCom has a PEG ratio of 1.3.
DXCM pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors